Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) SHZ

3.91

+0.03(+0.77%)

Updated at September 08 03:08PM

Currency In CNY

Valuation

Market Cap8.14B
Enterprise Value7.49B
P/E Ratio-245.03
PEG Ratio0.03
Price/Sales Ratio2.1
Price/Book Ratio1.37
Enterprise/Revenue1.96
Enterprise/EBITDA557.66

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.01
Operating Margin-0

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue5.78B
Revenue/Share1.85
Gross Profit3.05B
EBITDA445.46M
Net Income21.47M
Diluted EPS0.01

Balance Sheet

Total Cash1.33B
Total Cash/Share0.44
Total Debt504.86M
Total Debt/Equity0.06
Current Ratio3.97
Book Value Per Share2.91

Price History

52-Week Change22.57
52-Week High4.87
52-Week Low3.07
Moving Average 50 Days4.09
Moving Average 200 Days3.78

Statistics

Average Volume81.17M
Shares Outstanding3B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.77
Payout Ratio-2.78
Last Split Factor3:1
Last Split DateOctober 26, 2016